Showing results (791-800 of 1,033) with videos related to

Sort By:
Pageof 104
The Lancet. Respiratory Medicine|September 11, 2015
Cardiovascular and neuropsychiatric risks of varenicline: a retrospective cohort studyDaniel Kotz, Wolfgang Viechtbauer, Colin Simpson, et al.
The Lancet. Respiratory Medicine|January 20, 2016
Cardiac dysfunction during exacerbations of chronic obstructive pulmonary diseaseMartin I MacDonald, Eskandarain Shafuddin, Paul T King, et al.
The Lancet. Respiratory Medicine|January 23, 2016
BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysisJonathan D W Evans, Barbara Girerd, David Montani, et al.
The Lancet. Respiratory Medicine|May 16, 2016
Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort studySimon L F Walsh, Athol U Wells, Sujal R Desai, et al.
The Lancet. Respiratory Medicine|March 19, 2016
Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control studyMatthew R Moore, Ruth Link-Gelles, William Schaffner, et al.
The Lancet. Respiratory Medicine|November 8, 2017
Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trialDavid B Price, Roland Buhl, Adrian Chan, et al.
The Lancet. Respiratory Medicine|August 10, 2016
Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trialSherif Gonem, Rachid Berair, Amisha Singapuri, et al.
The Lancet. Respiratory Medicine|February 6, 2025
Estimated worldwide variation and trends in incidence of lung cancer by histological subtype in 2022 and over time: a population-based studyGanfeng Luo, Yanting Zhang, Harriet Rumgay, et al.
The Lancet. Respiratory Medicine|February 3, 2025
Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trialsSurya P Bhatt, Klaus F Rabe, Nicola A Hanania, et al.
The Lancet. Respiratory Medicine|January 13, 2025
Baseline characteristics of patients in the Chinese Bronchiectasis Registry (BE-China): a multicentre prospective cohort studyJin-Fu Xu, Hui-Zhen Zheng, Hai-Wen Lu, et al.
Pageof 104